Distribution of Diagnoses and Lesion Sizes in Each Phase of This Study
| Diagnosis | Phase 1 (555 MBq) YNHH | Phase 2 (370 MBq) YNHH | Phase 2 (3.7 MBq/kg) CNR/FTGM |
| Lymphoma | 1.4 ± 0.5 cm (0.5–2.4 cm), n = 17 | 1.3 ± 0.5 cm (0.6–2.5 cm), n = 10 | 1.2 ± 0.8 cm (0.6–2.7 cm), n = 6 |
| Lung cancer | 1.0 ± 0.4 cm (0.6–1.8 cm), n = 8 | 1.7 ± 0.7 cm (0.7–4.0 cm), n = 19 | 1.7 ± 0.8 cm (0.7–3.5 cm), n = 18 |
| Breast cancer | 2.2 ± 1.3 cm (0.5–4.3 cm), n = 4 | 1.4 ± 0.5 cm (0.8–2.9 cm), n = 12 | 1.8 ± 1.3 cm (0.9–2.7 cm), n = 2 |
| Pancreas cancer | 1.8 ± 0.7 cm (1.2–2.8 cm), n = 3 | 1.3 ± 0.9 cm (0.8–2.8 cm), n = 2 | Not applicable |
| Miscellaneous | 1.4 ± 1.0 cm (0.4–4.5 cm), n = 19 | Not applicable | Not applicable |
Data are average ± SD, followed by range in parentheses.